BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 11911277)

  • 1. Antileukemic activity of synthetic daunomycinone derivatives bearing modifications in the glycosidic moiety.
    Perchellet EM; Sperfslage BJ; McIlvain CJ; Aligiannis N; Pouli N; Marakos P; Skaltsounis AL; Perchellet JP
    Anticancer Res; 2001; 21(6A):3957-67. PubMed ID: 11911277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quinone isomers of the WS-5995 antibiotics: synthetic antitumor agents that inhibit macromolecule synthesis, block nucleoside transport, induce DNA fragmentation, and decrease the growth and viability of L1210 leukemic cells more effectively than ellagic acid and genistein in vitro.
    Perchellet EM; Sperfslage BJ; Qabaja G; Jones GB; Perchellet JP
    Anticancer Drugs; 2001 Jun; 12(5):401-17. PubMed ID: 11395569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,4-Anthraquinone: an anticancer drug that blocks nucleoside transport, inhibits macromolecule synthesis, induces DNA fragmentation, and decreases the growth and viability of L1210 leukemic cells in the same nanomolar range as daunorubicin in vitro.
    Perchellet EM; Magill MJ; Huang X; Dalke DM; Hua DH; Perchellet JP
    Anticancer Drugs; 2000 Jun; 11(5):339-52. PubMed ID: 10912950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Among substituted 9,10-dihydro-9,10-[1,2]benzenoanthracene-1,4,5,8-tetraones, the lead antitumor triptycene bisquinone TT24 blocks nucleoside transport, induces apoptotic DNA fragmentation and decreases the viability of L1210 leukemic cells in the nanomolar range of daunorubicin in vitro.
    Perchellet EM; Sperfslage BJ; Wang Y; Huang X; Tamura M; Hua DH; Perchellet JP
    Anticancer Drugs; 2002 Jul; 13(6):567-81. PubMed ID: 12172502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triptycenes: a novel synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, induce DNA cleavage and decrease the viability of leukemic cells in the nanomolar range in vitro.
    Perchellet EM; Magill MJ; Huang X; Brantis CE; Hua DH; Perchellet JP
    Anticancer Drugs; 1999 Sep; 10(8):749-66. PubMed ID: 10573208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic pyrone analogs: a new synthetic class of bifunctional anticancer drugs that inhibit nucleoside transport, microtubule assembly, the viability of leukemic cells in vitro and the growth of solid tumors in vivo.
    Perchellet EM; Ladesich JB; Magill MJ; Chen Y; Hua DH; Perchellet JP
    Anticancer Drugs; 1999 Jun; 10(5):489-504. PubMed ID: 10477169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of novel octalactin A analogs in murine leukemia cells in vitro.
    Perchellet JP; Perchellet EM; Newell SW; Freeman JA; Ladesich JB; Jeong Y; Sato N; Buszek K
    Anticancer Res; 1998; 18(1A):97-106. PubMed ID: 9568062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
    Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
    Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of DNA and RNA metabolism by daunorubicin and adriamycin in L1210 mouse leukemia.
    Meriwether WD; Bachur NR
    Cancer Res; 1972 Jun; 32(6):1137-42. PubMed ID: 5030814
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioactivity of synthetic 2-halo-3-aryl-4(3H)-quinazoliniminium halides in L1210 leukemia and SK-BR-3 mammary tumor cells in vitro.
    Perchellet JP; Waters AM; Perchellet EM; Naganaboina VK; Chandra KL; Desper J; Rayat S
    Anticancer Res; 2011 Jun; 31(6):2083-93. PubMed ID: 21737626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of novel tricyclic pyrone analogs in murine leukemia cells in vitro.
    Perchellet JP; Newell SW; Ladesich JB; Perchellet EM; Chen Y; Hua DH; Kraft SL; Basaraba RJ; Omura S; Tomoda H
    Anticancer Res; 1997; 17(4A):2427-34. PubMed ID: 9252658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lethal effect of adriamycin on the division cycle of HeLa cells.
    Kim SH; Kim JH
    Cancer Res; 1972 Feb; 32(2):323-5. PubMed ID: 5058189
    [No Abstract]   [Full Text] [Related]  

  • 13. Antitumor mechanisms of zinostatin stimalamer (YM881).
    Tanaka S; Yamamoto M; Numasaki Y
    Res Commun Mol Pathol Pharmacol; 1996 May; 92(2):165-76. PubMed ID: 8774070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of poly(ADP-ribose) polymerase-1 cleavage by antitumor triptycene bisquinones in wild-type and daunorubicin-resistant HL-60 cell lines.
    Wang Y; Perchellet EM; Tamura M; Hua DH; Perchellet JP
    Cancer Lett; 2002 Dec; 188(1-2):73-83. PubMed ID: 12406551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cytotoxicity of 3'-aminocyanoborane-2', 3'-dideoxypyrimidines in murine and human tissue cultured cell lines.
    Burnham BS; Chen SY; Sood A; Spielvogel BF; Miller MC; Hall IH
    Anticancer Res; 1995; 15(3):951-8. PubMed ID: 7645985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activity of 7-O-(2,6-dideoxy-2-fluoro-alpha-L-talopyranosyl) daunomycinone derivatives modified at C-3' or C-4'.
    Takagi Y; Kobayashi N; Chang MS; Lim GJ; Tsuchiya T
    Carbohydr Res; 1998 Feb; 307(3-4):217-32. PubMed ID: 9675364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of RNA synthesis in vitro and cell growth by anthracycline antibiotics.
    Studzian K; Wasowska M; Piestrzeniewicz MK; WilmaƄska D; Szmigiero L; Oszczapowicz I; Gniazdowski M
    Neoplasma; 2001; 48(5):412-8. PubMed ID: 11845988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic 1,4-anthracenediones, which block nucleoside transport and induce DNA fragmentation, retain their cytotoxic efficacy in daunorubicin-resistant HL-60 cell lines.
    Wu M; Wang B; Perchellet EM; Sperfslage BJ; Stephany HA; Hua DH; Perchellet JP
    Anticancer Drugs; 2001 Nov; 12(10):807-19. PubMed ID: 11707648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of action of a novel macromolecular antitumor antibiotic, SN-07, on mouse leukemia L1210 cells in culture.
    Yajima N; Miyata N; Kawanishi G; Katayama S; Tsukagoshi S
    Jpn J Cancer Res; 1987 Oct; 78(10):1121-7. PubMed ID: 3119545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade.
    Shen SC; Chen YC; Hsu FL; Lee WR
    J Cell Biochem; 2003 Aug; 89(5):1044-55. PubMed ID: 12874837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.